Clostridium innocuum is a significant vancomycin-resistant pathogen for extraintestinal clostridial infection

被引:42
作者
Chia, J. -H. [1 ,2 ,7 ]
Feng, Y. [3 ,4 ]
Su, L. -H. [1 ,2 ,5 ]
Wu, T. -L. [1 ,2 ]
Chen, C. -L. [5 ]
Liang, Y. -H. [5 ]
Chiu, C. -H. [5 ,6 ]
机构
[1] Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan
[2] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan
[3] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Hangzhou, Zhejiang, Peoples R China
[4] Zhejiang Univ, Sch Med, Inst Translat Med, Hangzhou, Zhejiang, Peoples R China
[5] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Mol Infect Dis Res Ctr, Taoyuan, Taiwan
[6] Chang Gung Univ, Chang Gung Childrens Hosp, Div Paediat Infect Dis, Dept Paediat,Coll Med, 5 Fu Hsin St, Taoyuan 333, Taiwan
[7] Eurofins Panlabs Ltd, Antiinfect Grp, Taipei, Taiwan
关键词
Clostridium innocuum; Extra-intestinal clostridial infection; MALDI-TOF; 16S rRNA sequencing; Vancomycin resistance; IN-VITRO ACTIVITY; DIFFICILE; BACTEREMIA; PERFRINGENS; METRONIDAZOLE; PATIENT;
D O I
10.1016/j.cmi.2017.02.025
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Extra-intestinal clostridial infection (EICI) is rare but can be fatal. Traditional phenotypic methods can only assign many of the Clostridium species to the genus level. Methods: A total of 376 non-repetitive Clostridium isolates from sterile sites were collected and subjected to matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) Biotyper analysis and 16S rRNA sequencing. Antimicrobial susceptibility was determined, and clinical characteristics of the patients were assessed. Clostridium innocuum isolates were characterized by genome sequencing and genotyping. We used molecular and cellular methods to explore the virulence and resistance mechanisms of C. innocuum. Results: Clostridium innocuum was the second most common species to cause EICI, only next to Clostridium perfringens. All Clostridium isolates showed susceptibility to clindamycin, metronidazole, penicillin, piperacillin and ampicillin-sulbatam, while C. innocuum isolates were invariably resistant to vancomycin. Among 24 patients with EICI caused by C. innocuum, two (8.3%) had diarrhoea, three (12.5%) had soft-tissue infection, six (25%) had appendicitis and four (16.7%) each had shock and gastrointestinal perforation. The 30-day mortality was 16.7%. The C. innocuum isolated from different sites could not be separated from one another by genotyping. No known toxin genes were identified in the genome of C. innocuum but the species expressed cytotoxicity to epithelial cells. D-Alanine-D-alanine ligase, alanine racemase and D-alanyl-D-alanine carboxypeptidase are three main genes responsible for vancomycin resistance in C. innocuum. Conclusions: Vancomycin-resistant C. innocuum is a previously unrecognized, yet prominent, cause for EICI. Genome analysis showed that the species could carry a lipopolysaccharide-like structure that is associated with cytotoxicity to cells in vitro. (C) 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:560 / 566
页数:7
相关论文
共 31 条
[1]   Isolation of Clostridium innocuum from cases of recurrent diarrhea in patients with prior Clostridium difficile associated diarrhea [J].
Ackermann, G ;
Tang, YJ ;
Jang, SS ;
Silva, J ;
Rodloff, AC ;
Cohen, SH .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 40 (03) :103-106
[2]   IDENTIFICATION AND ANTIMICROBIAL RESISTANCE PATTERNS OF CLINICAL ISOLATES OF CLOSTRIDIUM-CLOSTRIDIOFORME, CLOSTRIDIUM-INNOCUUM AND CLOSTRIDIUM-RAMOSUM COMPARED WITH THOSE OF CLINICAL ISOLATES OF CLOSTRIDIUM-PERFRINGENS [J].
ALEXANDER, CJ ;
CITRON, DM ;
BRAZIER, JS ;
GOLDSTEIN, EJC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (12) :3209-3215
[3]  
[Anonymous], 2016, Clinical Practice Guideline: Postpartum Haemorrhage, P1
[4]   Clostridium hastiforme is a later synonym of Tissierella praeacuta [J].
Bae, JW ;
Park, JR ;
Chang, YH ;
Rhee, SK ;
Kim, BC ;
Park, YH .
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, 2004, 54 :947-949
[5]  
BODEY GP, 1991, CANCER, V67, P1928, DOI 10.1002/1097-0142(19910401)67:7<1928::AID-CNCR2820670718>3.0.CO
[6]  
2-9
[7]  
Chen Yao-Ming, 2001, Journal of Microbiology Immunology and Infection, V34, P113
[8]   In vitro activity of cadazolid against clinically relevant Clostridium difficile isolates and in an in vitro gut model of C. difficile infection [J].
Chilton, C. H. ;
Crowther, G. S. ;
Baines, S. D. ;
Todhunter, S. L. ;
Freeman, J. ;
Locher, H. H. ;
Athanasiou, A. ;
Wilcox, M. H. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (03) :697-705
[9]   In vitro activity of oritavancin (LY333328), vancomycin, clindamycin, and metronidazole against Clostridium perfringens, Propionibacterium acnes, and anaerobic Gram-positive cocci [J].
Citron, DM ;
Kwok, YY ;
Appleman, MD .
ANAEROBE, 2005, 11 (1-2) :93-95
[10]  
CLSI, 2007, M11A7 CLSI